Type 2 Diabetes (T2DM)
41
15
18
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 41 trials
100.0%
+13.4% vs benchmark
20%
8 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (41)
The GRoceries Aimed at Increasing Nutrition Study
A Study of BGM0504 in Early T2DM With Obesity
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
CGM-Assisted Community Management for Type 2 Diabetes
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
DIabetes GLycemic Assessment in Newly Confirmed Episodes
Effect of Ajwa Seed Powder on HbA1c and Body Composition in Overweight and Obese Patients With Type 2 Diabetes Mellitus
TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy
HCC Risk and Monitoring in Patients With Type 2 Diabetes
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Remission Evaluation of Metabolic Interventions in Type 2 Diabetes in Primary Care (REMIT-Prime)
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
Influence of Gut Microbiota on the Development of Type 2 Diabetes Mellitus and Personalization of Diabetes-lowing Therapy
The Effect of OptiFibre Dietary Fiber on Carbohydrate Metabolism and Intestinal Microbiota Metabolism in Patients With Type 2 Diabetes Mellitus
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention
Women With Previous GDM and the Effects of HIIT.
Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol